Global Complex Regional Pain Syndrome (CRPS) Market

Table of Content

1. Introduction
   • Definition of Complex Regional Pain syndrome (CRPS) Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Complex Regional Pain syndrome (CRPS) Market, By Therapy Type:
   • Physical Therapy
   • Therapy via Drugs
     • Analgesics
     • Antidepressants
     • Corticosteroids
     • Others
   • Surgical Sympathectomy
   • Intrathecal Drug Pumps
   • Spinal Cord Stimulation
5. Complex Regional Pain syndrome (CRPS) Market, By Route of Administration:
   • Oral Therapy
   • Intravenous Therapy
6. Complex Regional Pain syndrome (CRPS) Market, By Distribution Channel:
   • Hospital Pharmacy
   • Drug Stores
   • Retail Pharmacy
   • E-Commerce
7. Complex Regional Pain syndrome (CRPS) Market, By Geography
   • North America
     • United States
     • Canada
   • Europe
     • United Kingdom
     • Germany
     • France
     • Spain
     • Italy
     • Rest of Europe
   • Asia-Pacific
     • China
     • Japan
     • India
     • South Korea
     • Australia
     • Rest of Asia-Pacific
   • Latin America
     • Brazil
     • Mexico
     • Rest of Latin America
   • Middle East & Africa
     • Saudi Arabia
     • United Arab Emirates
     • South Africa
     • Rest of Middle East & Africa
8. Competitive Landscape
9. Company Profiles
   • Mallinckrodt Pharmaceuticals
     • Company Overview
     • Product Portfolio and Description
     • Key Highlights
     • Financial Overview
   • GlaxoSmithKline plc.
   • Mylan N.V.
   • Teva Pharmaceutical Industries Ltd.
   • AbbVie
   • ACTAVIS
   • Zydus Pharmaceuticals Inc.
   • Sandoz
   • Janssen Global Services LLC.
   • Medline Plus
10. Conclusion and Future Outlook
11. Appendix
    • Research Methodology
    • About the Pharmanucleus

12. Disclaimer